Ticker > Company >

Advanced Enzyme share price

Advanced Enzyme Technologies Ltd.

NSE: ADVENZYMES BSE: 540025 SECTOR: Pharmaceuticals & Drugs  1.03 L   448   76

360.25
0 0
BSE: 01 Aug 04:01 PM

Price Summary

Today's High

₹ 366.55

Today's Low

₹ 352.75

52 Week High

₹ 571.15

52 Week Low

₹ 257.85

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

4030.52 Cr.

Enterprise Value

4024.69 Cr.

No. of Shares

11.19 Cr.

P/E

39.35

P/B

6.46

Face Value

₹ 2

Div. Yield

1.44 %

Book Value (TTM)

₹  55.81

CASH

5.83 Cr.

DEBT

0 Cr.

Promoter Holding

43.08 %

EPS (TTM)

₹  9.15

Sales Growth

-3.85%

ROE

17.04 %

ROCE

20.01%

Profit Growth

-5.27 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Advanced Enzyme Technologies Ltd.

evoxx DigeGrain DigePhos SEBrew SEBMash SEBake SEBStar SEBYeast Extractase Addclean

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-3.85%
3 Year8.81%
5 Year7.28%

Profit Growth

1 Year-5.27%
3 Year23.4%
5 Year12.06%

ROE%

1 Year17.04%
3 Year15.9%
5 Year15.48%

ROCE %

1 Year20.01%
3 Year19.72%
5 Year19.82%

Debt/Equity

0

Price to Cash Flow

63.49

Interest Cover Ratio

239.1976

CFO/PAT (5 Yr. Avg.)

0.73223219005447

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 43.08 0.00
Mar 2025 43.08 0.00
Dec 2024 42.93 0.00
Sep 2024 42.95 0.00
Jun 2024 43.02 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 23.395751551776% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 239.1976.
  • The Company has been maintaining an effective average operating margins of 26.92168% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 5.1945.

 Limitations

  • The company has shown a poor revenue growth of 8.8072139151274% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 30.389.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 92.4 85.96 77.38 100.87 87.21
Total Expenditure 63.16 65.04 63.85 78.81 73.04
Operating Profit 29.24 20.92 13.53 22.06 14.17
Other Income 3.21 53.88 1.66 1.43 4.53
Interest 0.05 0.02 0.08 0.06 0.08
Depreciation 3.07 2.62 2.78 2.89 3.11
Exceptional Items -18.95 0 0 0 0
Profit Before Tax 10.39 72.16 12.32 20.54 15.51
Tax 7.25 5.1 3.2 5.36 4.46
Profit After Tax 3.14 67.06 9.13 15.18 11.05
Adjusted EPS (Rs) 0.28 6 0.82 1.36 0.99

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 283.47 272.8 311.53 365.47 351.41
Total Expenditure 182.62 199.97 236.45 260.18 280.46
Operating Profit 100.85 72.83 75.08 105.29 70.95
Other Income 6.82 9.08 9.81 58.94 61.49
Interest 0.24 0.27 0.33 0.39 0.51
Depreciation 9.01 9.56 10.28 10.9 11.41
Exceptional Items 0 0 0 -18.95 0
Profit Before Tax 98.43 72.07 74.28 133.99 120.53
Tax 27.42 17.56 18.75 25.87 18.11
Net Profit 71.01 54.51 55.53 108.12 102.42
Adjusted EPS (Rs.) 6.36 4.88 4.97 9.67 9.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 22.35 22.36 22.37 22.37 22.38
Total Reserves 413.1 457.99 502.97 558.11 606.97
Borrowings 0.18 0 0 0 0
Other N/C liabilities 12.94 12.96 13.57 12.45 14.59
Current liabilities 41.04 36.31 36.9 40.01 44.7
Total Liabilities 489.6 529.62 575.8 632.93 688.63
Assets
Net Block 132.22 132.03 142.86 142.13 156.5
Capital WIP 1.96 3.25 5.61 16.45 20.74
Intangible WIP 5.38 5.44 5.42 5.41 0.02
Investments 151.56 172.68 185.48 205.49 253.71
Loans & Advances 35.14 35.76 38.36 14.73 19.46
Other N/C Assets 3.12 3.79 8.54 0.39 6.01
Current Assets 160.23 176.69 189.54 248.34 232.2
Total Assets 489.6 529.62 575.8 632.93 688.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 98.43 72.07 74.28 133.99 120.53
Adjustment 3.56 1.68 5.07 -23.59 -43.7
Changes in Assets & Liabilities 9.07 -15.21 -12.6 -31.57 8.19
Tax Paid -26.83 -21.44 -16.46 -27.21 -21.55
Operating Cash Flow 84.23 37.1 50.3 51.63 63.48
Investing Cash Flow -69.91 -14.24 -42.35 -2.7 -1.74
Financing Cash Flow -15.49 -10.87 -11.99 -56.88 -57.63
Net Cash Flow -1.16 11.99 -4.05 -7.95 4.11

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 43.02 42.95 42.93 43.08 43.08
jayesh madhusudan soni - 0.03 0.03 0.03 0.03
kishor laxminarayan rathi... 1.31 1.35 1.35 0.36 0.36
kishor laxminarayan rathi... - - - 0.98 0.98
madhusudan kabra 0.64 0.55 0.55 0.55 0.55
megha jhawar - 0.02 0.02 0.02 0.02
prabhavati vasant rathi 0.82 0.82 0.82 0.82 0.82
rachana vasant rathi 2.36 2.36 2.36 2.36 2.36
rasika vasant rathi 2.38 2.38 2.38 2.38 2.38
reshma namita rathi 2.37 2.37 2.37 2.37 2.37
snehal shamsunder soni - - - 0.01 0.01
vasant rathi 33.14 33.04 33.03 33.18 33.18
payal akshay kulkarni - 0.02 0.02 0.01 -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 56.98 57.05 57.07 56.92 56.92
clarus capital i 1.51 1.82 1.99 2.15 2.27
icici prudential pharma h... - - - 3.08 3.08
investor education and pr... - 0.11 - 0.11 0.11
marval guru fund - 1.00 1.00 1.00 1.00
mukund madhusudan kabra 1.63 1.63 1.63 1.63 1.63
nalanda india equity fund... 8.46 8.46 8.46 8.46 8.46
orbimed asia iii mauritiu... 12.08 12.08 12.07 12.07 12.07
pradip bhailal shah 1.80 1.71 1.70 1.70 1.70
hdfc small cap fund 3.33 3.02 2.96 - -
investor education and pr... 0.11 - 0.12 - -
icici prudential esg fund... 1.52 - - - -
llp 0.24 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research Emkay

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q4FY21
Concall Q3FY25
Concall Q3FY24
Concall Q3FY22
Concall Q2FY24
Concall Q2FY22
Concall Q2FY21
Concall Q1FY24
Concall Q1FY22
Concall Q1FY19
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY21
Presentation Q2FY20
Presentation Q1FY22
Presentation Q1FY21

Company News

Advanced Enzyme Stock Price Analysis and Quick Research Report. Is Advanced Enzyme an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Advanced Enzyme and its performance over the period of time. Advanced Enzyme stock price today is Rs 360.35.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Advanced Enzyme cash from the operating activity was Rs 63.479 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Advanced Enzyme has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Advanced Enzyme , the EPS growth was -5.3202 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Advanced Enzyme has OPM of 20.1897493248646 % which is a good sign for profitability.
     
  • ROE: Advanced Enzyme have a average ROE of 17.044 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Advanced Enzyme is Rs 360.35. One can use valuation calculators of ticker to know if Advanced Enzyme share price is undervalued or overvalued.
Last Updated on:
Brief about Advanced Enzyme
X